A carregar...

New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA

In the last few years, much new information has been generated on the pathophysiology, possible therapeutic targets, and pharmacologic treatment of overactive bladder (OAB). Antimuscarinic drugs are still first-line pharmacologic treatment for OAB and often have good initial response rates, but adve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Andersson, Karl-Erik
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3634323/
https://ncbi.nlm.nih.gov/pubmed/23637536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S33052
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!